CHRS vs GILD: Which Stock is Better?
Side-by-side comparison of Coherus BioSciences Inc and Gilead Sciences Inc in 2026
CHRS
Coherus BioSciences Inc
—
GILD
Gilead Sciences Inc
$131.27
Key Metrics Comparison
| Metric | CHRS | GILD | Winner |
|---|---|---|---|
| Market Cap | $223.66M | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze CHRS
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHRS or GILD a better investment?
Comparing CHRS and GILD: Coherus BioSciences Inc has a market cap of $223.66M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHRS and GILD?
CHRS (Coherus BioSciences Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHRS or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CHRS or GILD?
Both CHRS and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: CHRS or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: CHRS or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $223.66M for CHRS.
Should I buy CHRS or GILD in 2026?
Both CHRS and GILD have investment merit. CHRS trades at $N/A while GILD trades at $131.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHRS and GILD stock?
Key differences: Market Cap ($223.66M vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy CHRS or GILD in 2026?
The choice between CHRS and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between CHRS and GILD?
CHRS (Coherus BioSciences Inc) has a market cap of $223.66M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.